These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 32710675)

  • 1. Precision Neurology for Parkinson's Disease: Coupling Miro1-Based Diagnosis With Drug Discovery.
    Bharat V; Wang X
    Mov Disord; 2020 Sep; 35(9):1502-1508. PubMed ID: 32710675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LRRK2 impairs PINK1/Parkin-dependent mitophagy via its kinase activity: pathologic insights into Parkinson's disease.
    Bonello F; Hassoun SM; Mouton-Liger F; Shin YS; Muscat A; Tesson C; Lesage S; Beart PM; Brice A; Krupp J; Corvol JC; Corti O
    Hum Mol Genet; 2019 May; 28(10):1645-1660. PubMed ID: 30629163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nix restores mitophagy and mitochondrial function to protect against PINK1/Parkin-related Parkinson's disease.
    Koentjoro B; Park JS; Sue CM
    Sci Rep; 2017 Mar; 7():44373. PubMed ID: 28281653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired mitochondrial-endoplasmic reticulum interaction and mitophagy in Miro1-mutant neurons in Parkinson's disease.
    Berenguer-Escuder C; Grossmann D; Antony P; Arena G; Wasner K; Massart F; Jarazo J; Walter J; Schwamborn JC; Grünewald A; Krüger R
    Hum Mol Genet; 2020 May; 29(8):1353-1364. PubMed ID: 32280985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Emerging Role of
    Grossmann D; Berenguer-Escuder C; Chemla A; Arena G; Krüger R
    Front Neurol; 2020; 11():587. PubMed ID: 33041957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Miro proteins prime mitochondria for Parkin translocation and mitophagy.
    Safiulina D; Kuum M; Choubey V; Gogichaishvili N; Liiv J; Hickey MA; Cagalinec M; Mandel M; Zeb A; Liiv M; Kaasik A
    EMBO J; 2019 Jan; 38(2):. PubMed ID: 30504269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic approaches to enhance PINK1/Parkin mediated mitophagy for the treatment of Parkinson's disease.
    Miller S; Muqit MMK
    Neurosci Lett; 2019 Jul; 705():7-13. PubMed ID: 30995519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitophagy in Parkinson's Disease: From Pathogenesis to Treatment.
    Liu J; Liu W; Li R; Yang H
    Cells; 2019 Jul; 8(7):. PubMed ID: 31336937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Miro1 Marks Parkinson's Disease Subset and Miro1 Reducer Rescues Neuron Loss in Parkinson's Models.
    Hsieh CH; Li L; Vanhauwaert R; Nguyen KT; Davis MD; Bu G; Wszolek ZK; Wang X
    Cell Metab; 2019 Dec; 30(6):1131-1140.e7. PubMed ID: 31564441
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Wauters F; Cornelissen T; Imberechts D; Martin S; Koentjoro B; Sue C; Vangheluwe P; Vandenberghe W
    Autophagy; 2020 Feb; 16(2):203-222. PubMed ID: 30945962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. S-Nitrosylation of PINK1 Attenuates PINK1/Parkin-Dependent Mitophagy in hiPSC-Based Parkinson's Disease Models.
    Oh CK; Sultan A; Platzer J; Dolatabadi N; Soldner F; McClatchy DB; Diedrich JK; Yates JR; Ambasudhan R; Nakamura T; Jaenisch R; Lipton SA
    Cell Rep; 2017 Nov; 21(8):2171-2182. PubMed ID: 29166608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial Dysfunction and Mitophagy in Parkinson's Disease: From Mechanism to Therapy.
    Malpartida AB; Williamson M; Narendra DP; Wade-Martins R; Ryan BJ
    Trends Biochem Sci; 2021 Apr; 46(4):329-343. PubMed ID: 33323315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting mitophagy in Parkinson's disease.
    Clark EH; Vázquez de la Torre A; Hoshikawa T; Briston T
    J Biol Chem; 2021; 296():100209. PubMed ID: 33372898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-degron-mediated degradation and regulation of mitochondrial PINK1 kinase.
    Eldeeb MA; Ragheb MA
    Curr Genet; 2020 Aug; 66(4):693-701. PubMed ID: 32157382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Michael J. Fox Foundation for Parkinson's Research Strategy to Advance Therapeutic Development of PINK1 and Parkin.
    Padmanabhan S; Polinski NK; Menalled LB; Baptista MAS; Fiske BK
    Biomolecules; 2019 Jul; 9(8):. PubMed ID: 31344817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Steady-State Levels of Miro1 Linked to Phosphorylation at Serine 156 and Mitochondrial Respiration in Dopaminergic Neurons.
    Schwarz L; Fitzgerald JC
    Cells; 2022 Apr; 11(8):. PubMed ID: 35455950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Miro1 Impairment in a Parkinson's At-Risk Cohort.
    Nguyen D; Bharat V; Conradson DM; Nandakishore P; Wang X
    Front Mol Neurosci; 2021; 14():734273. PubMed ID: 34434090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial dysfunction and mitophagy defects in LRRK2-R1441C Parkinson's disease models.
    Williamson MG; Madureira M; McGuinness W; Heon-Roberts R; Mock ED; Naidoo K; Cramb KML; Caiazza MC; Malpartida AB; Lavelle M; Savory K; Humble SW; Patterson R; Davis JB; Connor-Robson N; Ryan BJ; Wade-Martins R
    Hum Mol Genet; 2023 Sep; 32(18):2808-2821. PubMed ID: 37384414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitophagy: the latest problem for Parkinson's disease.
    Vives-Bauza C; Przedborski S
    Trends Mol Med; 2011 Mar; 17(3):158-65. PubMed ID: 21146459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Huang Lian Jie Du Tang attenuates paraquat-induced mitophagy in human SH-SY5Y cells: A traditional decoction with a novel therapeutic potential in treating Parkinson's disease.
    Lee IJ; Chao CY; Yang YC; Cheng JJ; Huang CL; Chiou CT; Huang HT; Kuo YH; Huang NK
    Biomed Pharmacother; 2021 Feb; 134():111170. PubMed ID: 33383311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.